MedPath

A study comparing the effectiveness of Ketamine and ECT as an add-on therapy for severe depressive episodes with suicidal ideation.

Phase 4
Conditions
Health Condition 1: F332- Major depressive disorder, recurrent severe without psychotic features
Registration Number
CTRI/2023/06/053779
Lead Sponsor
avanya Seth
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients giving written informed consent or their representatives if the patients are too unwell to provide consent at the time of recruitment. HAM-D score more than or equal to 19. SSI score more than or equal to 4.

Exclusion Criteria

-Individuals diagnosed with dementia and/or mental retardation

-Individuals diagnosed with seizure disorder or severe head injury, severe medical/surgical illness or electrocardiogram abnormality

-Individuals having a history of schizophrenia or other psychotic disorders.

-Individuals diagnosed with Depression with psychotic features

-Individuals having a history of contraindications for ketamine or a history of ketamine abuse/dependence.(eg. Severe cardiovascular disease, elevated intra cranial pressure, severe liver disease, poorly controlled HTN)

-History of alcohol or substance dependence (except nicotine and caffeine) in the year prior to the study

-Women who are pregnant or breastfeeding.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath